- Home
- REI vs NYXH Comparison
REI vs NYXH Comparison
Compare REI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- NYXH
- Stock Information
- Founded
- REI 2004
- NYXH 2009
- Country
- REI United States
- NYXH Belgium
- Employees
- REI 115
- NYXH N/A
- Industry
- REI Oil & Gas Production
- NYXH Medical/Dental Instruments
- Sector
- REI Energy
- NYXH Health Care
- Exchange
- REI Nasdaq
- NYXH Nasdaq
- Market Cap
- REI 206.5M
- NYXH 185.5M
- IPO Year
- REI N/A
- NYXH 2021
- Fundamental
- Price
- REI $1.00
- NYXH $5.29
- Analyst Decision
- REI
- NYXH Strong Buy
- Analyst Count
- REI 0
- NYXH 3
- Target Price
- REI N/A
- NYXH $15.00
- AVG Volume (30 Days)
- REI 2.6M
- NYXH 75.1K
- Earning Date
- REI 11-06-2025
- NYXH 11-13-2025
- Dividend Yield
- REI N/A
- NYXH N/A
- EPS Growth
- REI N/A
- NYXH N/A
- EPS
- REI 0.35
- NYXH N/A
- Revenue
- REI $318,900,835.00
- NYXH $5,793,306.00
- Revenue This Year
- REI N/A
- NYXH $85.62
- Revenue Next Year
- REI $9.58
- NYXH $320.09
- P/E Ratio
- REI $2.90
- NYXH N/A
- Revenue Growth
- REI N/A
- NYXH 2.94
- 52 Week Low
- REI $0.72
- NYXH $4.35
- 52 Week High
- REI $1.77
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- REI 48.34
- NYXH 41.88
- Support Level
- REI $0.91
- NYXH $4.36
- Resistance Level
- REI $1.05
- NYXH $5.96
- Average True Range (ATR)
- REI 0.05
- NYXH 0.30
- MACD
- REI -0.01
- NYXH -0.05
- Stochastic Oscillator
- REI 35.97
- NYXH 9.69
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.